Depression Flashcards
Risk of reoccurance
Episode 1: 50-60%
Episode 2: 70%
Episode 3: 90%
Diagnosis
> or equal 5 with at least 1 being depressed or loss of interest
SIGE CAPS
Sleep, intertest decrease, guilt/worthlessness, energy loss, concentration difficulties, appetite loss, psychomotor agitation, suicidal ideation
Physiological
sleep, appetite, fatigue, clumsiness
Phycological
dysphoric mood, loss of interest, guilt, worthlessness
Cognitive
concentration difficulties, suicidal ideation
Biogenic amine
Reserpine causes depression by depleting NE and 5-HT from vesicles
NE and 5-HT are effective in depression
Genetic polymorphisms in SERT
Alterations in 5-HT1A/C and alpha 2 receptors
Neuroendocrine
Alterations in Hypothalamic-pituritary-adrenal axis (HPA)
Overactivity of the axis that causes increased activity of CRF
CRF1:arousal, anxiety, disruption in sex and sleep
Neurotropic
Depression, stress and pain patients have decreased BDNF levels
Loss of sprouts and hippocampal volume leads to depression
Antidepressant increase BDNF levels and hippocampal volume
MAO-I
MAO normally degrades NE and 5-HT
MAO-A: NE AND 5-HT
MAO-B: DA
Inhibition: increased amount of NE and 5-HT in vesicles released in synapse
Phenelzine and Tranylcypromine
drug resistant depression
Non-selective (irreversible)
Moclobemide
MAO-A selective (reversible)
Selegiline
MAO-B selective (reversible)
SE of MAO-I
HA, drowsiness, dry mouth, weight gain, orthostatic hypotension, sexual dysfunction
Hypertensive crisis: AVOID TYRAMINE
MAO normally degrades tyramine
Except selegiline 6 mg/24hr patch
Risk of serotonin syndrome: TCA, SSRI, L-DOPA
MUST HAVE 2 WEEK WASHOUT PERIOD BEFORE SWITCHING ANTIDEPRESSANT (5 WEEKS FOR FLUOXETINE)
TCA
Tertiary amines
Block SERT, NET, histamine 1, muscarinic, alpha -1
Imipramine
tertiary amine
metabolized to desipramine
Trimipramine
tertiary amine
Clomipramine
tertiary amine
causes orgasm when yawning
Amitriptyline
metabolized to nortriptyline
Doxepin
tertiary amine